APYX vs V · rev $48.1M vs P/E 33, rev $40.00B
Apyx Medical Inc (APYX) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
APYX currently screens at market cap $179.6M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the APYX and V stock pages for the full models.
Not investment advice.